Hi Ashley, I did a little bit of work on this a few years back. My belief is that the main difficulty with IHC for phospho-epitopes is not formalin fixation per se, but rather the instability of the phosphorylation. I used to work with rodent tumor models, where we collected solid tumors (or other tissues) just after sacrifice, and fixed them by formalin immersion. We found that the periphery of the tissues fixed this way expressed various phospho-epitopes quite well, but not the center. My interpretation was that by the time formalin had penetrated to the deep regions of the tissue, the phosphorylation had gone away (as you know formalin penetrates solid tissues fairly slowly). We proceeded to test matched tissue samples, fixed either in formalin at room temperature vs. cold formalin (formalin was at 4C at immersion, and the tissue was put in the fridge after sampling). We found that the cold formalin samples expressed phosphorylation sites fairly evenly, compared to only peripheral with the room temp samples. Presumably the cold temperature preserves the phosphorylation sites long enough to leave time for formalin to penetrate throughout. Consequently we integrated cold formalin fixation to all our IHC protocols for phospho-epitopes. Hope this helps,
Jean-Martin Lapointe Accellab -----Original Message----- Good day colleagues, Does anyone have any information on phospho antibodies and fixation? Is there any reason to NOT fix specimens in formalin vs say, 70% EtOH? (and then process them through formalin later?) I can't seem to find any information on whether or not fixation in formalin does something strange to a phosphorylated protien and makes it a less accessible antigen. Also, on that same note, does retreival do anything to it? I am assuming that these antibodies go through the same testing for cross reactivity, etc (depending on the vendor) and are reliable when used properly (like any other antibody). I don't, however, know if there is enough of a difference in the epitope (the fact that it is phosphorylated) that would make it more susceptible to some strange cross linking with formalin (especiallly with phosphate buffered formalin). Any help with this topic would be greatly appreciated as I am uneducated in this area. Thanks, Ashley Troutman BS, HT(ASCP) QIHC Vanderbilt University Histopathology 1301 Medical Center Drive TVC 4532 Nashville, TN 37232 615-343-9134 _______________________________________________ Histonet mailing list Histonet@lists.utsouthwestern.edu http://lists.utsouthwestern.edu/mailman/listinfo/histonet ------------------------------ _______________________________________________ Histonet mailing list Histonet@lists.utsouthwestern.edu http://lists.utsouthwestern.edu/mailman/listinfo/histonet End of Histonet Digest, Vol 77, Issue 21 ****************************************
_______________________________________________ Histonet mailing list Histonet@lists.utsouthwestern.edu http://lists.utsouthwestern.edu/mailman/listinfo/histonet